NCT05282017View on ClinicalTrials.gov

LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE Study

CompletedOBSERVATIONAL
Enrollment

792

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

April 19, 2023

Study Completion Date

April 19, 2023

Conditions
COVID-19, SARS-CoV-2
Trial Locations (9)

1102

Research Site, Bogotá

10108

Research Site, San José

44280

Research Site, Guadalajara

97000

Research Site, Mérida

760004

Research Site, Santiago de Cali

22211-230

Research Site, Brazil

41253-190

Research Site, Brazil

04501-000

Research Site, Brazil

0843-01103

Research Site, Panama City

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY